These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25045820)

  • 21. Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.
    Costantino C; Restivo V; Tramuto F; Casuccio A; Vitale F
    Hum Vaccin Immunother; 2018; 14(9):2297-2302. PubMed ID: 29757707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the impact of childhood influenza vaccination less than expected: a transmission modelling study.
    Weidemann F; Remschmidt C; Buda S; Buchholz U; Ultsch B; Wichmann O
    BMC Infect Dis; 2017 Apr; 17(1):258. PubMed ID: 28399801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?
    Pitzer VE; Bilcke J; Heylen E; Crawford FW; Callens M; De Smet F; Van Ranst M; Zeller M; Matthijnssens J
    Sci Rep; 2015 Dec; 5():18585. PubMed ID: 26687288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
    Ultsch B; Damm O; Beutels P; Bilcke J; Brüggenjürgen B; Gerber-Grote A; Greiner W; Hanquet G; Hutubessy R; Jit M; Knol M; von Kries R; Kuhlmann A; Levy-Bruhl D; Perleth M; Postma M; Salo H; Siebert U; Wasem J; Wichmann O
    Pharmacoeconomics; 2016 Mar; 34(3):227-44. PubMed ID: 26477039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany.
    Koch J; Wiese-Posselt M; Remschmidt C; Wichmann O; Bertelsmann H; Garbe E; Hengel H; Meerpohl JJ; Mas Marques A; Oppermann H; Hummers-Pradier E; von Kries R; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Jul; 56(7):957-84. PubMed ID: 23807405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines.
    Uhlig U; Kostev K; Schuster V; Koletzko S; Uhlig HH
    Pediatr Infect Dis J; 2014 Nov; 33(11):e299-304. PubMed ID: 24911897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mathematical model of the indirect effects of rotavirus vaccination.
    Van Effelterre T; Soriano-Gabarró M; Debrus S; Claire Newbern E; Gray J
    Epidemiol Infect; 2010 Jun; 138(6):884-97. PubMed ID: 20028612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan.
    de Blasio BF; Kasymbekova K; Flem E
    Vaccine; 2010 Nov; 28(50):7923-32. PubMed ID: 20933563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.
    Giaquinto C; Dominiak-Felden G; Van Damme P; Myint TT; Maldonado YA; Spoulou V; Mast TC; Staat MA
    Hum Vaccin; 2011 Jul; 7(7):734-48. PubMed ID: 21734466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.
    Rha B; Tate JE; Payne DC; Cortese MM; Lopman BA; Curns AT; Parashar UD
    Expert Rev Vaccines; 2014 Mar; 13(3):365-76. PubMed ID: 24392657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned.
    Pereira P; Vetter V; Standaert B; Benninghoff B
    Expert Rev Vaccines; 2020 Aug; 19(8):755-769. PubMed ID: 32729747
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.